Haemonetics | 8-K: Current report
Apr 1 08:06 ET
Haemonetics | 8-K: Current report
Mar 5 06:13 ET
Haemonetics | 8-K: Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2024 Results; Updates Fiscal 2024 Guidance
Feb 8 06:10 ET
Haemonetics | 8-K: Current report
Dec 12, 2023 06:09 ET
Haemonetics | 8-K: Haemonetics Reports Second Quarter and First Half Fiscal 2024 Results; Updates Fiscal 2024 Guidance
Nov 2, 2023 06:16 ET
Haemonetics | 8-K/A: Current report (Amendment)
Oct 12, 2023 06:10 ET
Haemonetics | 8-K: Current report
Oct 10, 2023 06:06 ET
Haemonetics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 11, 2023 16:10 ET
Haemonetics | 8-K: Haemonetics Reports First Quarter Fiscal 2024 Results; Updates Fiscal 2024 Guidance
Aug 8, 2023 06:01 ET
Haemonetics | 8-K: Current report
Aug 7, 2023 16:19 ET
Haemonetics | DEFA14A: Others
Jun 16, 2023 06:10 ET
Haemonetics | DEF 14A: Definitive information statements
Jun 16, 2023 06:08 ET
Haemonetics | 8-K: Haemonetics Reports Fourth Quarter and Fiscal 2023 Results; Provides Fiscal 2024 Guidance
May 11, 2023 06:05 ET
Haemonetics | 8-K: Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2023 Results; Updates Fiscal 2023 Guidance
Feb 7, 2023 06:09 ET
Haemonetics | 8-K: Haemonetics Reports Second Quarter and First Half Fiscal 2023 Results; Updates Fiscal 2023 Guidance
Nov 7, 2022 06:03 ET
Haemonetics | 8-K: Current report
Oct 19, 2022 17:15 ET
Haemonetics | 8-K: Haemonetics Reports First Quarter Fiscal 2023 Results; Updates Fiscal 2023 Guidance; Announces New $300 Million Share Repurchase Authorization
Aug 10, 2022 06:06 ET
Haemonetics | 8-K: Current report
Aug 8, 2022 17:04 ET
Haemonetics | 8-K: Current report
Aug 1, 2022 16:11 ET
Haemonetics | DEFA14A: Others
Jun 17, 2022 06:19 ET
No Data
No Data